(Q46988098)

English

Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming

scientific article published on 21 April 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/27109567

Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/27109567

0 references

Fatima Laraba-Djebari

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Faez Amokrane Nait Mohamed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Faez Amokrane Nait Mohamed

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/27109567

language of work or name

0 references

publication date

21 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/27109567

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

2692-2699

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Controlled delivery of antigens and adjuvants in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Effect of gamma irradiation on toxicity and immunogenicity of Androctonus australis hector venom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

IrradiatedCerastes cerastesVenom as a Novel Tool for Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Enhanced immune sera and vaccine: Safe approach to treat scorpion envenoming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Nanoparticles in cancer therapy and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Hydrogel nanoparticles in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Polymer-based nanocapsules for drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Nanoparticulate systems for the delivery of antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Preparation methods of alginate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: Comparative role of MF59 and Alum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Development of a new drug carrier made from alginate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Alginate nanoparticles as a promising adjuvant and vaccine delivery system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Melatonin protects against pro‐oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Microparticles as vaccine adjuvants and delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Biomaterials as vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Immunological properties of engineered nanomaterials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Nanotoxoid Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Role of neutrophils in spinal cord injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Evaluation of nanoparticle immunotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Nanoparticles and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Alginate-based sustained release drug delivery systems for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Interaction of nanoparticles with immunocompetent cells: nanosafety considerations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

The supramolecular structure of LPS-chitosan complexes of varied composition in relation to their biological activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.035

7 January 2021

Identifiers

10.1016/J.VACCINE.2016.04.035

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109567%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46988098&oldid=2140964075"